371 related articles for article (PubMed ID: 26245294)
1. A complementary role for tetraspanin superfamily member CD151 and ADP purinergic P2Y12 receptor in platelets.
Makkawi M; Moheimani F; Alserihi R; Howells D; Wright M; Ashman L; Jackson DE
Thromb Haemost; 2015 Nov; 114(5):1004-19. PubMed ID: 26245294
[TBL] [Abstract][Full Text] [Related]
2. A complementary role for tetraspanin superfamily member TSSC6 and ADP purinergic P2Y
Makkawi M; Howells D; Wright MD; Jackson DE
Thromb Res; 2018 Jan; 161():12-21. PubMed ID: 29178985
[TBL] [Abstract][Full Text] [Related]
3. The tetraspanin superfamily member CD151 regulates outside-in integrin alphaIIbbeta3 signaling and platelet function.
Lau LM; Wee JL; Wright MD; Moseley GW; Hogarth PM; Ashman LK; Jackson DE
Blood; 2004 Oct; 104(8):2368-75. PubMed ID: 15226180
[TBL] [Abstract][Full Text] [Related]
4. The kinetics of αIIbβ3 activation determines the size and stability of thrombi in mice: implications for antiplatelet therapy.
Stolla M; Stefanini L; Roden RC; Chavez M; Hirsch J; Greene T; Ouellette TD; Maloney SF; Diamond SL; Poncz M; Woulfe DS; Bergmeier W
Blood; 2011 Jan; 117(3):1005-13. PubMed ID: 20971951
[TBL] [Abstract][Full Text] [Related]
5. Homozygous loss of mouse tetraspanin CD82 enhances integrin αIIbβ3 expression and clot retraction in platelets.
Uchtmann K; Park ER; Bergsma A; Segula J; Edick MJ; Miranti CK
Exp Cell Res; 2015 Dec; 339(2):261-9. PubMed ID: 26562164
[TBL] [Abstract][Full Text] [Related]
6. A clopidogrel-insensitive inducible pool of P2Y12 receptors contributes to thrombus formation: inhibition by elinogrel, a direct-acting, reversible P2Y12 antagonist.
Haberstock-Debic H; Andre P; Mills S; Phillips DR; Conley PB
J Pharmacol Exp Ther; 2011 Oct; 339(1):54-61. PubMed ID: 21730013
[TBL] [Abstract][Full Text] [Related]
7. Differential sensitivity and kinetics of response of different ex vivo tests monitoring functional variability of platelet response to clopidogrel.
Bal Dit Sollier C; Berge N; Boval B; Dubar M; Drouet L
Thromb Haemost; 2010 Sep; 104(3):571-81. PubMed ID: 20664906
[TBL] [Abstract][Full Text] [Related]
8. Impaired "outside-in" integrin alphaIIbbeta3 signaling and thrombus stability in TSSC6-deficient mice.
Goschnick MW; Lau LM; Wee JL; Liu YS; Hogarth PM; Robb LM; Hickey MJ; Wright MD; Jackson DE
Blood; 2006 Sep; 108(6):1911-8. PubMed ID: 16720835
[TBL] [Abstract][Full Text] [Related]
9. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.
Foster CJ; Prosser DM; Agans JM; Zhai Y; Smith MD; Lachowicz JE; Zhang FL; Gustafson E; Monsma FJ; Wiekowski MT; Abbondanzo SJ; Cook DN; Bayne ML; Lira SA; Chintala MS
J Clin Invest; 2001 Jun; 107(12):1591-8. PubMed ID: 11413167
[TBL] [Abstract][Full Text] [Related]
10. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.
Malinin A; Pokov A; Spergling M; Defranco A; Schwartz K; Schwartz D; Mahmud E; Atar D; Serebruany V
Thromb Res; 2007; 119(3):277-84. PubMed ID: 16563469
[TBL] [Abstract][Full Text] [Related]
11. Dependence of platelet thrombus stability on sustained glycoprotein IIb/IIIa activation through adenosine 5'-diphosphate receptor stimulation and cyclic calcium signaling.
Goto S; Tamura N; Ishida H; Ruggeri ZM
J Am Coll Cardiol; 2006 Jan; 47(1):155-62. PubMed ID: 16386680
[TBL] [Abstract][Full Text] [Related]
12. Distinct roles for Rap1b protein in platelet secretion and integrin αIIbβ3 outside-in signaling.
Zhang G; Xiang B; Ye S; Chrzanowska-Wodnicka M; Morris AJ; Gartner TK; Whiteheart SW; White GC; Smyth SS; Li Z
J Biol Chem; 2011 Nov; 286(45):39466-77. PubMed ID: 21940635
[TBL] [Abstract][Full Text] [Related]
13. The effect of P2Y12 inhibition on platelet activation assessed with aggregation- and flow cytometry-based assays.
Leunissen TC; Wisman PP; van Holten TC; de Groot PG; Korporaal SJ; Koekman AC; Moll FL; Teraa M; Verhaar MC; de Borst GJ; Urbanus RT; Roest M
Platelets; 2017 Sep; 28(6):567-575. PubMed ID: 27885904
[TBL] [Abstract][Full Text] [Related]
14. The role of ADP receptors in platelet function.
Murugappa S; Kunapuli SP
Front Biosci; 2006 May; 11():1977-86. PubMed ID: 16368572
[TBL] [Abstract][Full Text] [Related]
15. Effect of clopidogrel administration to healthy volunteers on platelet phosphorylation events triggered by ADP.
Contreres JO; Dupuy E; Job B; Habib A; Bryckaert M; Rosa JP; Simoneau G; Herbert JM; Savi P; Levy-Toledano S
Br J Haematol; 2003 Feb; 120(4):633-42. PubMed ID: 12588350
[TBL] [Abstract][Full Text] [Related]
16. Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses.
Judge HM; Buckland RJ; Holgate CE; Storey RF
Platelets; 2005 Nov; 16(7):398-407. PubMed ID: 16236601
[TBL] [Abstract][Full Text] [Related]
17. NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling, hemostasis and arterial thrombosis.
Qiao J; Wu X; Luo Q; Wei G; Xu M; Wu Y; Liu Y; Li X; Zi J; Ju W; Fu L; Chen C; Wu Q; Zhu S; Qi K; Li D; Li Z; Andrews RK; Zeng L; Gardiner EE; Xu K
Haematologica; 2018 Sep; 103(9):1568-1576. PubMed ID: 29794149
[TBL] [Abstract][Full Text] [Related]
18. Isorhapontigenin, a resveratrol analogue selectively inhibits ADP-stimulated platelet activation.
Ravishankar D; Albadawi DAI; Chaggar V; Patra PH; Williams HF; Salamah M; Vaiyapuri R; Dash PR; Patel K; Watson KA; Vaiyapuri S
Eur J Pharmacol; 2019 Nov; 862():172627. PubMed ID: 31461638
[TBL] [Abstract][Full Text] [Related]
19. The platelet P2 receptors as molecular targets for old and new antiplatelet drugs.
Gachet C
Pharmacol Ther; 2005 Nov; 108(2):180-92. PubMed ID: 15955565
[TBL] [Abstract][Full Text] [Related]
20. Glycoprotein IIb/IIIa and P2Y12 induction by oligochitosan accelerates platelet aggregation.
Periayah MH; Halim AS; Yaacob NS; Saad AZ; Hussein AR; Rashid AH; Ujang Z
Biomed Res Int; 2014; 2014():653149. PubMed ID: 25247182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
